Tahithromos’s Archrock AROC Stock Holding History

Tahithromos’s Portfolio AROC Stock Details AROC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-89,553	Closed	-$673K	–	15
2015 Q4	$673K	Sell	89,553 -740	-0.8%	-$10.6K	0.64%	20
2015 Q3	$1.63M	Sell	90,293 -32,747	-27%	-$784K	1.51%	11
2015 Q2	$4.02M	Sell	123,040 -127,263	-51%	-$4.3M	5.52%	6
2015 Q1	$8.4M	Sell	250,303 -57,331	-19%	-$1.75M	3.89%	10
2014 Q4	$10M	Sell	307,634 -52,764	-15%	-$1.88M	4.81%	9
2014 Q3	$16M	Buy	+360,398	New	+$15.8M	4.15%	10

Other funds holding AROC

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Tahithromos's AROC Position: Q1 2016 in Review

Tahithromos sold out of Archrock (AROC) in Q1 2016, closing a stake of 89,553 shares — an estimated $673K sold.

Tahithromos first reported a position in AROC in Q3 2014 and held it in 6 quarters. The position peaked at $16M in Q3 2014. 164 funds tracked by Wall St. Rank hold AROC as of Q1 2016.

Tahithromos reported no remaining Archrock position as of Q1 2016 after selling out during the quarter.
Tahithromos sold 89,553 Archrock shares in Q1 2016, an estimated $673K.
Tahithromos first reported a position in Archrock in Q3 2014 and held it in 6 quarters.
Tahithromos's Archrock position peaked at $16M in Q3 2014.
164 funds tracked by Wall St. Rank held Archrock as of Q1 2016.

Based on Tahithromos's 13F filing for Q1 2016, filed 5 May 2016.